Improving risk prediction performance for a better guidelines application.
aDepartamento de Preclínicas, Escuela de Medicina, Universidad de Valparaíso, Valparaíso, Chile bService de Pharmacologie Clinique, Centre Hospitalier Régional et Universitaire de Tours, Tours cCNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Service de, Pharmacologie Clinique, Lyon, France.
Ivanny
I
Marchant
Theodora
T
Bejan-Angoulvant
Ha Ha
HH
Le
François
F
Gueyffier
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007668:Kidney / Q000503:physiopathology*; D008297:Male; D018570:Risk Assessment / Q000379:methods*
D000959:Antihypertensive Agents